AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...
Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound.
The breakthrough could simplify the production of complex proteins used in cancer immunotherapy and other advanced medicines ...
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule ...
Boron agents termed GluBs, developed by Science Tokyo researchers, have overcome a key limitation in cancer therapy by ...
Boron agents termed GluBs, developed by Science Tokyo researchers, overcome a key limitation in cancer therapy by entering tumor cells through a ...
"Project Hail Mary" is wholesome science fiction that satisfies like a jumbo serving of apple pie and milk. A middle school ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results